Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Researchers developed an innovative artificial complex, Cu@G-antimicrobial peptides, which shows great potential in ...

GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications ...

Count podcast host Joe Rogan, 57, among the fans of BPC-157 — he reported that it cleared up his elbow tendonitis in just two ...

A research group in Korea has discovered a novel natural antimicrobial peptide, "Hirunipin-2," from the salivary glands of ...

The novel drug reduces the need for burdensome phlebotomy and also addresses fatigue, thereby improving quality of life for ...

Four clinical organizations jointly release an advisory with evidence-based nutrition and lifestyle interventions to enhance ...

MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

Nibec Co. Ltd. announced May 28 the signing of a potential $435 million license deal for NP-201, its phase II-ready peptide-based pulmonary fibrosis therapy candidate, with an undisclosed U.S.-based ...

The list includes everything from the award-winning Glazing Milk to Ariana Grande-approved peptide lip treatments.

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...